RAD51AP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.55846471680843E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.17119999990479E-07 |
Normal-vs-Stage2 |
8.978700E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.175500E-03 |
Stage1-vs-Stage2 |
6.579200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.747600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.840800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.49720014164245E-10 |
Normal-vs-AfricanAmerican |
2.017000E-01 |
Normal-vs-Asian |
8.729500E-02 |
Caucasian-vs-AfricanAmerican |
5.224400E-01 |
Caucasian-vs-Asian |
9.118000E-01 |
AfricanAmerican-vs-Asian |
6.137200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.83389999994532E-06 |
Normal-vs-Female |
7.5685000044956E-08 |
Male-vs-Female |
3.031400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.037390E-03 |
Normal-vs-Extreme_Weight |
1.75488999999418E-05 |
Normal-vs-Obese |
4.176900E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.757200E-01 |
Normal_Weight-vs-Obese |
6.174400E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.257200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.750620E-01 |
Normal-vs-Age(41-60Yrs) |
1.221190E-04 |
Normal-vs-Age(61-80Yrs) |
8.16250000035268E-07 |
Normal-vs-Age(81-100Yrs) |
1.518450E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.805200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.005400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.194200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.834200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.880000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.142000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.399560E-02 |
Normal-vs-Grade 3 |
3.659200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.640000E-02 |
Grade 2-vs-Grade 4 |
1.399560E-02 |
Grade 3-vs-Grade 4 |
3.659200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.21320000104441E-08 |
Normal-vs-N1 |
3.498600E-03 |
N0-vs-N1 |
6.050200E-02 |
|
|